• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Participating Faculty: Prostate Cancer Management: Enhancing Cost-Effectiveness and Patient Outcomes

Publication
Article
Supplements and Featured PublicationsProstate Cancer Management: Enhancing Cost-Effectiveness and Patient Outcomes [CME/CPE]
Volume 20
Issue 12 Suppl

Prostate cancer is the most common cancer and the second-leading cause of death among men in the United States. It is associated with significant clinical and economic burden. This supplement to The American Journal of Managed Care is intended to provide a clinical understanding of prostate cancer, discuss current, new, and evolving treatment strategies for early-stage, recurrent, and advanced prostate cancer, and discuss the economic burden of the disease.Faculty

Robert Dreicer, MD, MS, FACP, FASCO

Director, GU Medical Oncology

Taussig Cancer Institute

Cleveland Clinic

Cleveland, Ohio

Professor of Medicine

Cleveland Clinic Lerner College of Medicine

Cleveland, Ohio

Deputy Associate Director of Clinical Research

Case Comprehensive Cancer Center

Cleveland, Ohio

Michael Kolodziej, MD, FACP

National Medical Director

Oncology Solutions

Aetna

Hartford, Connecticut

Neal Shore, MD, FACS

Medical Director

Carolina Urologic Research Center (CURC)

Atlantic Urology Clinics

Myrtle Beach, South Carolina

Editorial Support

Paige Davies, PhD

Hitt Medical Writing, LLC

Alpharetta, Georgia

Emma Nichols, PhD

Hitt Medical Writing, LLC

Alpharetta, Georgia

Kim Tran-Kerr, MD

Hitt Medical Writing, LLC

Alpharetta, Georgia

Faculty Disclosures

Robert Dreicer, MD, MS, FACP, FASCO, has disclosed the following relevant commercial financial relationships or affiliations in the past 12 months:

Consultant:

Astellas Pharma, Janssen Pharmaceuticals, Inc, Medivation, Inc, Merck, Millennium Pharmaceuticals, Inc, Roche

Honoraria: Astellas Pharma

Michael Kolodziej, MD, FACP, has disclosed the following relevant commercial financial relationships or affiliations in the past 12 months:

Stock/shareholder: Aetna

Neal Shore, MD, FACS, has no relevant financial relationships with commercial interests to disclose.

Editorial Support

Paige Davies, PhD; Emma Nichols, PhD; and Kim Tran-Kerr, MD, have no relevant financial relationships with commercial interests to disclose.

The American Journal of Managed Care

Publishing Staff—Jeff D. Prescott, PharmD, RPh; Ida Delmendo; and Tara Petersen have no relevant financial relationships with commercial interests to disclose.

University of Cincinnati

Planning staff—Susan P. Tyler, MEd, CMP, CCMEP, Director, University of Cincinnati, has no relevant

financial relationships with commercial interests to disclose.

CME Physician Reviewer—Rick Ricer, MD, University of Cincinnati, has no relevant financial relationships

with commercial interests to disclose.

Pharmacy Times Office of Continuing Professional Education

Planning staff—David Heckard; Steve Lin, PharmD, RPh; Donna Fausak; and Nathalie Harden have no relevant financial relationships with commercial interests to disclose.

© 2024 MJH Life Sciences
AJMC®
All rights reserved.